Abstract:PURPOSE:Glaucoma is a distinct neuropathy characterized by the chronic and progressive death of retinal ganglion cells (RGCs). The etiology of RGC death remains unknown. Risk factors for glaucomatous RGC death are elevated intraocular pressure and glial production of tumor necrosis factor-alpha (TNF-α). Previously, the authors showed that glaucoma causes a rapid upregulation of a neurotrophin receptor truncated isoform lacking the kinase domain, TrkC.T1, in retina. Here they examined the biological role of TrkC.T1 during glaucoma progression. METHODS:Rat and mouse models of chronic ocular hypertension were used. Immunofluorescence Western blot analysis and in situ mRNA hybridization were used to identify cells upregulating TrkC.T1. A genetic model of engineered mice lacking TrkC.T1 (TrkC.T1(-/-)) was used to validate a role for this receptor in glaucoma. Pharmacologic studies were conducted to evaluate intravitreal delivery of agonists or antagonists of TrkC.T1, compared with controls, during glaucoma. Surviving RGCs were quantified by retrograde-labeling techniques. Production of neurotoxic TNF-α and α2 macroglobulin were quantified. RESULTS:TrkC.T1 was upregulated in retinal glia, with a pattern similar to that of TNF-α. TrkC.T1(-/-) mice had normal retinas. However, during experimental glaucoma, TrkC.T1(-/-) mice had lower rates of RGC death and produced less TNF-α than wild-type littermates. In rats with glaucoma, the pharmacologic use of TrkC antagonists delayed RGC death and reduced the production of retinal TNF-α. CONCLUSIONS:TrkC.T1 is implicated in glaucomatous RGC death through the control of glial TNF-α production. Overall, the data point to a paracrine mechanism whereby elevated intraocular pressure upregulated glial TrkC.T1 expression in glia; TrkC.T1 controlled glial TNF-α production, and TNF-α caused RGC death.

TrkA in vivo function is negatively regulated by ubiquitination.

Cell Survival through Trk Neurotrophin Receptors Is Differentially Regulated by Ubiquitination

Cbl-b modulated TrkA ubiquitination and function in the dorsal root ganglion of mice

Brn3a Regulation of TrkA/NGF Receptor Expression in Developing Sensory Neurons.

Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements

Mklf7, a Potential Transcriptional Regulator of TrkA Nerve Growth Factor Receptor Expression in Sensory and Sympathetic Neurons.

703 Aberrant Antigen Presenting Cells Activate Effector T Cells and Inhibit Regulatory T Cell Function

Modifications in the C-terminal tail of TrkC significantly alter neurotrophin-3-promoted outgrowth of neurite-like processes from PC12 cells

Nerve Growth Factor Receptor TrkA Exists As a Preformed, Yet Inactive, Dimer in Living Cells

The TrkC-PTPσ complex governs synapse maturation and anxiogenic avoidance via synaptic protein phosphorylation

Molecular Characterization of the TrkA/NGF Receptor Minimal Enhancer Reveals Regulation by Multiple Cis Elements to Drive Embryonic Neuron Expression.

The Nerve Growth Factor Receptor TrkA Exists As a Pre‐formed Homodimer Before Ligand Binding

BDNF modulated KCC2 ubiquitylation in spinal cord dorsal horn of mice

Impaired neurotrophin-3 signaling in a TrkAII mutant associated with hereditary polyneuropathy

Function and Mechanisms of Truncated BDNF Receptor TrkB.T1 in Neuropathic Pain

Inhibitory Modulation Of Distal C-Terminal On Protein Kinase C-Dependent Phospho-Regulation Of Rat Trpv1 Receptors

TrkAIII: A Novel Hypoxia-regulated Alternative TrkA Splice Variant of Potential Physiological and Pathological Importance

Distinct Requirements for TrkB and TrkC Signaling in Target Innervation by Sensory Neurons

Chronic and Acute Models of Retinal Neurodegeneration TrkA Activity Are Neuroprotective Whereas P75ntr Activity is Neurotoxic Through a Paracrine Mechanism

Neuropilin-1 is a co-receptor for NGF and TrkA-evoked pain

In glaucoma the upregulated truncated TrkC.T1 receptor isoform in glia causes increased TNF-alpha production, leading to retinal ganglion cell death.